Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
Genitsaridi, Irini, Flouri, Irini, Plexousakis, Dimitris, Marias, Konstantinos, Boki, Kyriaki, Skopouli, Fotini, Drosos, Alexandros, Bertsias, George, Boumpas, Dimitrios, Sidiropoulos, ProdromosТом:
22
Журнал:
Arthritis Research & Therapy
DOI:
10.1186/s13075-020-02313-w
Date:
December, 2020
Файл:
PDF, 1.14 MB
2020
File converter
Більше результатів пошуку
More benefits 
